House appropriators’ report published with their fiscal year 2025 appropriation bill for the US Food and Drug Administration could signal a shift in members’ thinking about the agency’s approach to effective regulation of the hemp products market.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?